Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liza B John

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cancer Immunology Research|February 13, 2015
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell ResponsesPaul A Beavis, Nicole Milenkovski, Melissa A Henderson, et al.
Oncotarget|May 7, 2016
A role for multiple chimeric antigen receptor-expressing leukocytes in antigen-specific responses to cancerCarmen S M Yong, Liza B John, Christel Devaud, et al.
Plos One|May 14, 2013
Engineering T cell function using chimeric antigen receptors identified using a DNA library approachConnie P M Duong, Jennifer A Westwood, Carmen S M Yong, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2013
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumorsPaul A Beavis, Upulie Divisekera, Christophe Paget, et al.
Oncoimmunology|May 6, 2015
Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumorsChristel Devaud, Jennifer A Westwood, Michele Wl Teng, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2011
Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in miceSally M Amos, Hollie J Pegram, Jennifer A Westwood, et al.
Plos One|September 30, 2014
Foxp3 expression in macrophages associated with RENCA tumors in miceChristel Devaud, Carmen S M Yong, Liza B John, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2013
Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cellsLiza B John, Christel Devaud, Connie P M Duong, et al.
Immunotherapy|June 4, 2013
Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptorMelissa A Henderson, Carmen S M Yong, Connie P M Duong, et al.
Cancer Research|February 9, 2012
Oncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancerLiza B John, Linda J Howland, Jacqueline K Flynn, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Immunology Research|February 13, 2015
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell ResponsesPaul A Beavis, Nicole Milenkovski, Melissa A Henderson, et al.
Oncotarget|May 7, 2016
A role for multiple chimeric antigen receptor-expressing leukocytes in antigen-specific responses to cancerCarmen S M Yong, Liza B John, Christel Devaud, et al.
Plos One|May 14, 2013
Engineering T cell function using chimeric antigen receptors identified using a DNA library approachConnie P M Duong, Jennifer A Westwood, Carmen S M Yong, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 22, 2013
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumorsPaul A Beavis, Upulie Divisekera, Christophe Paget, et al.
Oncoimmunology|May 6, 2015
Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumorsChristel Devaud, Jennifer A Westwood, Michele Wl Teng, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2011
Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in miceSally M Amos, Hollie J Pegram, Jennifer A Westwood, et al.
Plos One|September 30, 2014
Foxp3 expression in macrophages associated with RENCA tumors in miceChristel Devaud, Carmen S M Yong, Liza B John, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2013
Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cellsLiza B John, Christel Devaud, Connie P M Duong, et al.
Immunotherapy|June 4, 2013
Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptorMelissa A Henderson, Carmen S M Yong, Connie P M Duong, et al.
Cancer Research|February 9, 2012
Oncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancerLiza B John, Linda J Howland, Jacqueline K Flynn, et al.
Pageof 3